Literature DB >> 15962932

Identification and quantification of the depurinating DNA adducts formed in mouse skin treated with dibenzo[a,l]pyrene (DB[a,l]P) or its metabolites and in rat mammary gland treated with DB[a,l]P.

Ercole L Cavalieri1, Eleanor G Rogan, Kai-Ming Li, Rosa Todorovic, Freek Ariese, Ryszard Jankowiak, Nenad Grubor, Gerald J Small.   

Abstract

Dibenzo[a,l]pyrene (DB[a,l]P) is the most potent carcinogenic polycyclic aromatic hydrocarbon and has been identified in the environment. Comparative tumorigenicity studies in mouse skin and rat mammary gland indicate that DB[a,l]P is slightly more potent than DB[a,l]P-11,12-dihydrodiol and much more potent than (+/-)-syn-DB[a,l]P-11,12-dihydrodiol-13,14-epoxide {(+/-)-syn-DB[a,l]PDE} and (+/-)-anti-DB[a,l]PDE. We report here the identification and quantification of the depurinating adducts formed in mouse skin treated with DB[a,l]P, DB[a,l]P-11,12-dihydrodiol, (+/-)-syn-DB[a,l]PDE, or (+/-)-anti-DB[a,l]PDE and rat mammary gland treated with DB[a,l]P. The biologically formed adducts were compared with standard adducts by their retention times on HPLC and their spectra obtained by fluorescence line-narrowing spectroscopy at low temperature. In mouse skin treated with DB[a,l]P, depurinating adducts comprised 99% of the total adducts. Most of the depurinating adducts were formed by one-electron oxidation, with 63% at Ade and 12% at Gua. The remainder were formed by the diol epoxide, with 18% at Ade and 6% at Gua. When mouse skin was treated with DB[a,l]P-11,12-dihydrodiol, depurinating adducts comprised 80% of the total, and the predominant one was with Ade (69%). Treatment of skin with (+/-)-syn-DB[a,l]PDE resulted in 32% depurinating adducts, primarily at Ade (25%), whereas treatment with (+/-)-anti-DB[a,l]PDE produced 97% stable adducts. The formation of depurinating adducts following treatment of rat mammary gland with DB[a,l]P resulted in approximately 98% depurinating adducts, with the major adducts formed by one-electron oxidation. Only one depurinating diol epoxide adduct was formed. Tumorigenicity, mutations, and DNA adduct data suggest that depurinating Ade adducts play a major role in the initiation of tumors by DB[a,l]P.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15962932     DOI: 10.1021/tx049682k

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  13 in total

1.  Mechanism of DNA depurination by carcinogens in relation to cancer initiation.

Authors:  Ercole Cavalieri; Muhammad Saeed; Muhammad Zahid; David Cassada; Daniel Snow; Momcilo Miljkovic; Eleanor Rogan
Journal:  IUBMB Life       Date:  2011-12-09       Impact factor: 3.885

Review 2.  The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.

Authors:  Ercole Cavalieri; Eleanor Rogan
Journal:  Mol Aspects Med       Date:  2013-08-30

3.  Cytochrome P450 1b1 in polycyclic aromatic hydrocarbon (PAH)-induced skin carcinogenesis: Tumorigenicity of individual PAHs and coal-tar extract, DNA adduction and expression of select genes in the Cyp1b1 knockout mouse.

Authors:  Lisbeth K Siddens; Kristi L Bunde; Tod A Harper; Tammie J McQuistan; Christiane V Löhr; Lisa M Bramer; Katrina M Waters; Susan C Tilton; Sharon K Krueger; David E Williams; William M Baird
Journal:  Toxicol Appl Pharmacol       Date:  2015-06-03       Impact factor: 4.219

Review 4.  Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers.

Authors:  Ercole L Cavalieri; Eleanor G Rogan
Journal:  Future Oncol       Date:  2010-01       Impact factor: 3.404

Review 5.  Environmental factors in causing human cancers: emphasis on tumorigenesis.

Authors:  Umesh T Sankpal; Hima Pius; Moeez Khan; Mohammed I Shukoor; Pius Maliakal; Chris M Lee; Maen Abdelrahim; Sarah F Connelly; Riyaz Basha
Journal:  Tumour Biol       Date:  2012-05-22

6.  Dibenzo[def,p]chrysene (DBC) suppresses antibody formation in spleen cells following oral exposures of mice.

Authors:  Fredine T Lauer; Mary K Walker; Scott W Burchiel
Journal:  J Toxicol Environ Health A       Date:  2013

7.  The etiology and prevention of breast cancer.

Authors:  Ercole L Cavalieri; Eleanor G Rogan
Journal:  Drug Discov Today Dis Mech       Date:  2012

8.  Biodegradation of a mixture of PAHs by non-ligninolytic fungal strains isolated from crude oil-contaminated soil.

Authors:  Anaisell Reyes-César; Ángel E Absalón; Francisco J Fernández; Juan Manuel González; Diana V Cortés-Espinosa
Journal:  World J Microbiol Biotechnol       Date:  2013-10-17       Impact factor: 3.312

9.  The role of polycyclic aromatic hydrocarbon-DNA adducts in inducing mutations in mouse skin.

Authors:  Dhrubajyoti Chakravarti; Divya Venugopal; Paula C Mailander; Jane L Meza; Sheila Higginbotham; Ercole L Cavalieri; Eleanor G Rogan
Journal:  Mutat Res       Date:  2007-09-07       Impact factor: 2.433

Review 10.  Human aldo-keto reductases and the metabolic activation of polycyclic aromatic hydrocarbons.

Authors:  Trevor M Penning
Journal:  Chem Res Toxicol       Date:  2014-10-16       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.